Get access to our best features
Get access to our best features
Published 1 year ago

Pfizer seeks FDA authorization for omicron vaccine in kids under 5

Summary by The Hill
Pfizer and its German partner BioNTech have submitted an application asking the Food and Drug Administration for emergency use authorization of their omicron-adapted bivalent COVID-19 vaccine as the third shot in a three-dose series for children ages 6 months through 4 years, the companies announced Monday. 

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 72% of the sources are Center
72% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)